> May be in the West. However more practical countries like China with a huge population and clear incentive to provide healthcare to a large population at reduced cost will have incentives to balance accuracy and usefulness in a better way.

This is a really interesting point that I haven't considered. Namely, regulatory arbitrage is going to yield enormous benefits in the medical AI space. The sheer amount of data needed to train the model requires data centralization the west has no desire to move toward. But if China does crack the nut, it seems like it will necessarily create an upheaval in the west, whether we like it or not.